id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-349031-tbof9yqi	Chen, Shiu-Jau	Novel Antiviral Strategies in the Treatment of COVID-19: A Review	2020-08-20		.txt	text/plain	5473	235	38	Nord experience Clinical trials on drug repositioning for COVID-19 treatment COVID-19 pandemic: An overview of epidemiology, parthenogenesis, diagnostics and potential vaccines and therapeutics Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment Convalescent plasma in Covid-19: Possible mechanisms of action Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma Effectiveness of convalescent plasma therapy in severe COVID-19 patients Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 Treatment with convalescent plasma for COVID-19 patients in Wuhan Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea Deployment of convalescent plasma for the prevention and treatment of COVID-19 Convalescent plasma transfusion for the treatment of COVID-19: Systematic review Potential application of the CRISPR/Cas9 system against herpesvirus infections Gene editing technologies and Applications Opioid addiction, genetic susceptibility and medical treatments: A Review Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza Mesenchymal stem cell therapy for COVID-19: Present or future Current status of cell-based therapies for respiratory virus infections: Applicability to COVID-19 Transplantation of ACE2-Mesenchymal stem cells improve the outcome of patients with COVID-19 pneumonia Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically Ill COVID-19 patients: The case for compassionate use Convalescent plasma therapy for persistent hepatitis E virus infection Convalescent plasma new evidence for an old therapeutic tool Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia Use of convalescent plasma in Ebola virus infection Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital Use of convalescent plasma therapy in SARS patients in Hong Kong Convalescent plasma as a potential therapy for COVID-19 Collecting and evaluating convalescent plasma for COVID-19 treatment: In this review, we explore the applications, possible mechanisms, and efficacy in successful cases using convalescent plasma, CRISPR, and MSC therapy for COVID-19 treatment, respectively.	cache/cord-349031-tbof9yqi.txt	txt/cord-349031-tbof9yqi.txt
